Tratamento de Lesão Cerebral Traumática Leve com Estimulação Transcraniana de Corrente Contínua de Alta Definição (HDtDCS-TBI)
Tratamento de déficits de recuperação verbal em traumatismo cranioencefálico leve com estimulação transcraniana por corrente contínua de alta definição
The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., presupplementary motor area) thought to aid in memory will improve verbal retrieval in military veteran participants with histories of traumatic brain injuries. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures. Additionally, the study will examine the degree to which baseline assessments of cognition and concussion history predict responses to treatment over time, both on assessments administered within the intervention period and at follow-up.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Using two treatment arms, the study will examine improvement of verbal retrieval and other cognitive deficits associated with remote traumatic brain injury by comparing (1) 1 milliamp transcranial direct current stimulation (tDCS) active treatment applied to presupplementary motor area for 20 minutes over 15 sessions to (2) sham tDCS following the same schedule. Additionally, after completing the initial active or sham treatment and 3-month follow-up testing sessions, selected participants will be invited back for newly assigned treatment conditions, 20 minutes over 15 sessions and will be and re-evaluated at 2- and 3-months follow-up testing sessions.
Veterans with histories of traumatic brain injuries and observed cognitive deficits will be randomly assigned to one of the two treatment arms (and re-assigned for the second round of intervention, as described above). Primary outcome verbal retrieval measures, secondary neuropsychological and electroencephalography (EEG) measures, and prescreening assessments for study concussion history and contraindications for treatment will be collected prior to being assigned to a treatment arm (i.e., baseline).
Primary outcome verbal retrieval measures and secondary neuropsychological and electroencephalography (EEG) measures will be collected after treatment sessions 5, 10, and 15 and two times following treatment competition (i.e., 2-months and 3-months). For participants selected for the second round of intervention, primary outcome verbal memory measures and secondary neuropsychological and electroencephalography (EEG) measures will be collected again after treatment sessions 5, 10, and 15 and two times following competition of the second treatment (i.e., 2-months and 3-months).
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Jill Ritter, BS
- Número de telefone: 972-883-3161
- E-mail: neurolab.memory@utdallas.edu
Estude backup de contato
- Nome: Tyler Vintila
- Número de telefone: 972-883-3161
- E-mail: neurolab.memory@utdallas.edu
Locais de estudo
-
-
Texas
-
Dallas, Texas, Estados Unidos, 75235
- Recrutamento
- The University of Texas at Dallas
-
Subinvestigador:
- Michael Motes, PhD
-
Contato:
- Ashna Adhikari
- Número de telefone: 972-883-3161
- E-mail: neurolab.memory@utdallas.edu
-
Contato:
- Tyler Vintila
- Número de telefone: 972-883-3161
- E-mail: neurolab.memory@utdallas.edu
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria: Participants are to be between the ages of 18-75, have previously served in the US armed services, and have had a traumatic brain injury that has led to a verbal retrieval deficit based on neuropsychological testing criteria. Traumatic brain injury must be in the mild to moderate range based on evaluation, including, the Ohio State TBI Identification Method (administered by our research group). You must be fluent in speaking and reading English.
Exclusion Criteria: Exclusion criteria include a history of a psychological or neurological disorder, including, dementia of any type, epilepsy or other seizure disorders, severe traumatic brain injury, post-traumatic stress disorder, brain tumor, present drug abuse, stroke, blood vessel abnormalities in the brain, Parkinson's disease, Huntington's disease, or multiple sclerosis. Additionally, exclusion criteria include inability to give informed consent; cranial implants or skull defects that affect tDCS administration; and use of medications that interact with or potentially interact with tDCS effects, including, anti-convulsants, amphetamines, L-dopa, carbamazepine, sulpiride, pergolide, lorazepam, rivastigmine, dextromethorphan, D-cycloserine, flunarizine, ropinirole, or citalopram.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Triplo
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Transcranial direct current stimulation
20 minutes of 1 milliamp transcranial direct current stimulation to presupplementary motor area for 15 sessions |
Transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. Stimulation will consist of 1 milliamp stimulation, with anodal stimulation delivered at electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, then remain at 1 milliamp of stimulation over 20 minutes, and finally ramping down at to 0 milliamps over 60 seconds.
Outros nomes:
|
|
Comparador Falso: Sham transcranial direct current stimulation
20 minutes of sham transcranial direct current stimulation to presupplementary motor area for 15 sessions |
Sham transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. The sham setup will consist of anodal electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, ramp down to 0 milliamps over 60 seconds and then be left off for 20 minutes. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Controlled Oral Word Association Test
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Control Word Association Test from baseline to 3-months. Metric: Number of Correct Items Generated Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Controlled Oral Word Association Test
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Control Word Association Test from baseline to 2-months. Metric: Number of Correct Items Generated Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment in Category Fluency
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Category Fluency from baseline to 3-months. Metric: Number of Correct Items Generated Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment in Category Fluency
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Category Fluency from baseline to 2-months. Metric: Number of Correct Items Generated Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Semantic Object Retrieval Test
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Semantic Object Retrieval Test from baseline to 3-months. Metric: Number of Correct Retrievals Kaplan, E., Goodglass, H., & Weintraub, S., (1983). Boston Naming Test (2nd ed.). Lea & Febiger: Philadelphia. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Semantic Object Retrieval Test
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Semantic Object Retrieval Test from baseline to 2-months. Metric: Number of Correct Retrievals Kaplan, E., Goodglass, H., & Weintraub, S., (1983). Boston Naming Test (2nd ed.). Lea & Febiger: Philadelphia. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Boston Naming Test
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Boston Naming Test from baseline to 3-months. Metric: Number of Correct Names Retrieved Kraut, M.A., Cherry, B., Pitcock, C.B., Anand, R., Li, J. Vestal, L., Henderson, V.W., and Hart, J. Jr. (2007). The Semantic Object Retrieval Test (SORT) in amnestic cognitive impairment. Cogn. Behav. Neurol. 20, 62- 67. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Boston Naming Test
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Boston Naming Test from baseline to 2-months. Metric: Number of Correct Names Retrieved Kraut, M.A., Cherry, B., Pitcock, C.B., Anand, R., Li, J. Vestal, L., Henderson, V.W., and Hart, J. Jr. (2007). The Semantic Object Retrieval Test (SORT) in amnestic cognitive impairment. Cogn. Behav. Neurol. 20, 62- 67. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on California Verbal Learning Test
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in California Verbal Learning Test from baseline to 3-months. Metric: Number of Correct Retrievals Delis DC, Kramer JH, Kaplan E, Ober BA. (2017). California verbal learning test (3rd Ed.). Pearson Publishing: San Antonio, TX. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on California Verbal Learning Test
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in California Verbal Learning Test from baseline to 2-months. Metric: Number of Correct Retrievals Delis DC, Kramer JH, Kaplan E, Ober BA. (2017). California verbal learning test (3rd Ed.). Pearson Publishing: San Antonio, TX. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Trail Making Test (Part A)
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Trail Making Test (Part A) from baseline to 3-months. Metric: Time to Solution Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Trail Making Test (Part A)
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Trail Making Test (Part A) from baseline to 2-months. Metric: Time to Solution Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Trail Making Test (Part B)
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Trail Making Test (Part B) from baseline to 3-months. Metric: Time to Solution Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Trail Making Test (Part B)
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Trail Making Test (Part B) from baseline to 2-months. Metric: Time to Solution Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Delis Kaplan Color Word Interference Test
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Delis Kaplan Color Word Interference Test from baseline to 3-months. Metric: Time to Name Items Delis, D.C., Kaplan, E., & Kramer, J.H., (2001). Delis-Kaplan Executive Function System. San Antonio, TX: The Psychological Corporation. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Delis Kaplan Color Word Interference Test
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Trail Making Test (Part B) from baseline to 2-months. Metric: Time to Name Items Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Digit Span Forward
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Digit Span Forward from baseline to 3-months. Metric: Memory Span Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Digit Span Forward
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Digit Span Forward from baseline to 2-months. Metric: Memory Span Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Digit Span Backward
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Digit Span Backward from baseline to 3-months. Metric: Memory Span Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Digit Span Backward
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Digit Span Backward from baseline to 2-months. Metric: Memory Span Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Rey-Osterrieth Complex Figure Test
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Rey-Osterrieth Complex Figure Test scores from baseline to 3-months. Metric: Score Rey, A. (1941). L'examen psychologique dans les cas d'encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.]. Archives de Psychologie, 28, 215- 285. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Rey-Osterrieth Complex Figure Test
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Rey-Osterrieth Complex Figure Test scores from baseline to 2-months. Metric: Score Rey, A. (1941). L'examen psychologique dans les cas d'encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.]. Archives de Psychologie, 28, 215- 285. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Digit Symbol Substitution Test
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Digit Symbol Substitution Test from baseline to 3-months. Metric: Number of Items Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Digit Symbol Substitution Test
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Digit Symbol Substitution Test from baseline to 2-months. Metric: Number of Items Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Grooved Pegboard Test
Prazo: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Grooved Pegboard Test from baseline to 3-months. Metric: Completion Time Matthews, C.G., and Klove, H. (1964). Instruction manual for the adult neuropsychology test. Madison. Wis: University of Wisconsin Medical School. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Grooved Pegboard Test
Prazo: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Grooved Pegboard Test from baseline to 2-months. Metric: Completion Time Matthews, C.G., and Klove, H. (1964). Instruction manual for the adult neuropsychology test. Madison. Wis: University of Wisconsin Medical School. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: John Hart, MD, The University of Texas at Dallas
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Doenças Cerebrais
- Doenças do Sistema Nervoso Central
- Doenças do Sistema Nervoso
- Ferimentos e Lesões
- Trauma Craniocerebral
- Trauma, Sistema Nervoso
- Lesões cerebrais
- Lesões Cerebrais Traumáticas
- Terapêutica
- Disciplinas e atividades comportamentais
- Terapia de estimulação elétrica
- Terapia convulsiva
- Terapias somáticas psiquiátricas
- ElectroShock
- Técnicas psicológicas
- Estimulação de corrente direta transcraniana
Outros números de identificação do estudo
- UTD-TDCSTBI-21-15
- CDMRP-PT190081 (Outro identificador: CDMRP)
- W81XWH-20-1-0846 (Número de outro subsídio/financiamento: DOD-CDMRP-USAMRDC)
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .